Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy (Q38001330)

26 August 2017

Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy (English)

1 reference

26 August 2017

1 reference

Shuji Terai

1

1 reference

26 August 2017

Haruko Tanimoto

2

1 reference

26 August 2017

Masaki Maeda

3

1 reference

26 August 2017

Junichi Zaitsu

4

1 reference

26 August 2017

Takuro Hisanaga

5

1 reference

26 August 2017

Takuya Iwamoto

6

1 reference

26 August 2017

Koichi Fujisawa

7

1 reference

26 August 2017

Yuko Mizunaga

8

1 reference

26 August 2017

Toshihiko Matsumoto

9

1 reference

26 August 2017

Yohei Urata

10

1 reference

26 August 2017

Yoshio Marumoto

11

1 reference

26 August 2017

Isao Hidaka

12

1 reference

26 August 2017

Tsuyoshi Ishikawa

13

1 reference

26 August 2017

Yuichiro Yokoyama

14

1 reference

26 August 2017

Koji Aoyama

15

1 reference

26 August 2017

Masako Tsuchiya

16

1 reference

26 August 2017

Taro Takami

17

1 reference

26 August 2017

Kaoru Omori

18

1 reference

26 August 2017

Naoki Yamamoto

19

1 reference

26 August 2017

Makoto Segawa

20

1 reference

26 August 2017

Koichi Uchida

21

1 reference

26 August 2017

Takahiro Yamasaki

22

1 reference

26 August 2017

Kiwamu Okita

23

1 reference

26 August 2017

Isao Sakaida

24

1 reference

26 August 2017

5 April 2012

1 reference

Journal of Gastroenterology

26 August 2017

1 reference

26 August 2017

47

1 reference

26 August 2017

5

1 reference

26 August 2017

491-497

1 reference

Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation

26 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes

21 January 2018

1 reference

12 December 2020

Bone marrow stem cells and liver disease

1 reference

12 December 2020

Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

1 reference

12 December 2020

Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis

1 reference

12 December 2020

Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.

1 reference

12 December 2020

Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial

1 reference

12 December 2020

Granulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice

1 reference

12 December 2020

Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4.

1 reference

12 December 2020

Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

1 reference

12 December 2020

Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice

1 reference

12 December 2020

10.1007/S00535-012-0580-5

Identifiers

DOI

1 reference

26 August 2017

1 reference